• 1
    Fukui I, Sekine H, Kihara K et al. Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder. J. Urol. 1989; 141: 5314.
  • 2
    Sekine H, Fukui I, Yamada T, Yamada T, Kojima S, Ohshima H. Histological grading of carcinoma in situ of the bladder: Its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy. J. Urol. 1996; 155: 949.
  • 3
    Hudson MA & Herr HW. Carcinoma in situ of the bladder. J. Urol. 1995; 153: 56472.
  • 4
    Herr HW, Badalament RA, Amato DA et al. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. J. Urol. 1989; 141: 229.
  • 5
    Harland SJ, Charig CR, Highman W, Parkinson MC, Riddle PR. Outcome in carcinoma in situ of bladder treated with intravesical bacille Calmette-Guerin. Br. J. Urol. 1992; 70: 2715.
  • 6
    Sarkis AS, Dalbagni G, Cordon-Cardo C et al. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression. J. Natl Cancer Inst. 1993; 85: 539.
  • 7
    Sarkis AS, Dalbagni G, Cordon-Cardo C et al. Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J. Urol. 1994; 152: 38892.
  • 8
    Cordon-Cardo C, Dalbagni G, Saez GT et al. p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns. Int. J. Cancer 1994; 56: 34753.
  • 9
    Underwood MA, Reeves J, Smith G et al. Over-expression of p53 and its significance for recurrent progressive bladder tumors. Br. J. Urol. 1996; 77: 65966.
  • 10
    Vollmer RT, Humphrey PA, Swanson PE, Wick MR, Hudson ML. Invasion of the bladder by transitional cell carcinoma: Its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor, and bcl-2. Cancer 1998; 82: 71523.
  • 11
    Lipponen PK. Over-expression of the p53 nuclear oncoprotein in transitional cell carcinoma of the bladder and its prognostic value. Int. J. Cancer 1993; 53: 36570.